C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 47/48 (2006.01) C07K 14/475 (2006.01) C12N 9/48 (2006.01) C12N 9/96 (2006.01) C12N 15/18 (2006.01) C12N 15/57 (2006.01)
Patent
CA 2243533
The invention provides a two component system for use in association with one another comprising; (a) a ligand fusion protein or conjugate with an enzyme capable of targeting the surface of a cell; and (b) a prodrug which can be converted into an active drug by said enzyme, useful in the treatment of tumours.
L'invention concerne un système à deux composantes destinées à être utilisées en association l'une avec l'autre, ces deux composantes étant: (a) une protéine fusionnée à un ligand ou un conjugué comprenant un enzyme capable de cibler la surface d'une cellule; et (b) un promédicament que l'on peut convertir en un médicament actif à l'aide dudit enzyme, utile dans le traitement des tumeurs.
Marais Richard
Springer Caroline Joy
Cancer Research Campaign Technology Limited
Kirby Eades Gale Baker
LandOfFree
Ligand directed enzyme prodrug therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ligand directed enzyme prodrug therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ligand directed enzyme prodrug therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1831285